HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of ciprofloxacin alone and in combination with azlocillin in experimental endocarditis due to Pseudomonas aeruginosa.

Abstract
The efficacy of ciprofloxacin alone and in combination with azlocillin was compared with that of azlocillin plus tobramycin in a rat model of aortic valve endocarditis due to Pseudomonas aeruginosa. MICs against the infecting strain of ciprofloxacin, azlocillin and tobramycin were 0.125, 8, and 0.5 mg/l, respectively. Antimicrobials were administered 24 h after bacterial challenge and for six days. Mean peak/trough serum levels for ciprofloxacin (50 mg/kg i.v. q 12 h), azlocillin (500 mg/kg i.v. q 12 h) and tobramycin (6.5 mg/kg i.v. q 12 h) were: 10.5/0.2, 386/less than 16, and 6.2/less than 0.6 mg/l, respectively. Ciprofloxacin alone was more effective than the combination azlocillin-tobramycin in increasing survival (p less than 0.05), sterilizing blood (p less than 0.05) and valves (p less than 0.001), and in reducing bacterial titers in vegetations (p less than 0.001). Ciprofloxacin-azlocillin combination was not more effective than ciprofloxacin alone. Drug resistance was not encountered in post-treatment isolates with any therapy regimen.
AuthorsC Thauvin, F Lecomte, I Le Boete, G Grise, J F Lemeland
JournalInfection (Infection) 1989 Jan-Feb Vol. 17 Issue 1 Pg. 31-4 ISSN: 0300-8126 [Print] Germany
PMID2493429 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Ciprofloxacin
  • Azlocillin
  • Tobramycin
Topics
  • Animals
  • Aortic Valve
  • Azlocillin (blood, pharmacology, therapeutic use)
  • Ciprofloxacin (blood, pharmacology, therapeutic use)
  • Drug Therapy, Combination
  • Endocarditis, Bacterial (drug therapy)
  • Heart Valve Diseases (drug therapy)
  • Male
  • Pseudomonas Infections (drug therapy)
  • Pseudomonas aeruginosa (drug effects, isolation & purification)
  • Rats
  • Rats, Inbred Strains
  • Tobramycin (blood, pharmacology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: